GROUP ONE TRADING, L.P. - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125C909. A total of 6 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$4,038,750
+36.8%
35,900
+14.7%
0.01%
+55.6%
Q2 2023$2,951,590
+3.0%
31,300
+10.6%
0.01%
-10.0%
Q1 2023$2,864,526
-75.9%
28,300
-71.6%
0.01%
-64.3%
Q4 2022$11,908,168
+416.6%
99,700
+359.4%
0.03%
+460.0%
Q3 2022$2,305,000
-35.9%
21,700
-41.2%
0.01%
-16.7%
Q2 2022$3,597,000
+31.4%
36,900
+26.4%
0.01%
+100.0%
Q1 2022$2,738,000
+12.8%
29,200
+2.5%
0.00%
+50.0%
Q4 2021$2,427,000
+116.3%
28,500
+143.6%
0.00%
+100.0%
Q3 2021$1,122,000
-62.9%
11,700
-62.4%
0.00%
-75.0%
Q2 2021$3,027,000
-38.5%
31,100
-38.5%
0.00%
-42.9%
Q1 2021$4,921,000
+64.0%
50,600
+61.7%
0.01%
+40.0%
Q4 2020$3,000,000
+124.4%
31,300
+125.2%
0.01%
+25.0%
Q3 2020$1,337,000
+115.0%
13,900
+172.5%
0.00%
+33.3%
Q2 2020$622,000
-61.4%
5,100
-72.6%
0.00%
-76.9%
Q1 2020$1,610,000
-60.9%
18,600
-51.4%
0.01%
-53.6%
Q4 2019$4,117,000
+552.5%
38,300
+447.1%
0.03%
+460.0%
Q3 2019$631,000
+96.6%
7,000
+84.2%
0.01%
+66.7%
Q2 2019$321,000
-57.7%
3,800
-55.8%
0.00%
-62.5%
Q1 2019$758,000
-15.1%
8,600
-31.2%
0.01%0.0%
Q4 2018$893,000
+503.4%
12,500
+941.7%
0.01%
+700.0%
Q3 2018$148,000
-97.6%
1,200
-98.1%
0.00%
-98.1%
Q2 2018$6,140,000
+161.6%
62,500
+120.8%
0.05%
+120.8%
Q1 2018$2,347,000
+51.2%
28,300
+41.5%
0.02%
+118.2%
Q4 2017$1,552,000
+1997.3%
20,000
+1566.7%
0.01%
+1000.0%
Q3 2017$74,000
-95.1%
1,200
-96.4%
0.00%
-93.8%
Q2 2017$1,513,000
+56.0%
32,900
+46.9%
0.02%
+45.5%
Q1 2017$970,000
+31.3%
22,400
+17.3%
0.01%
+57.1%
Q4 2016$739,000
-89.4%
19,100
-86.1%
0.01%
-90.7%
Q3 2016$6,943,000
-6.0%
137,100
-15.6%
0.08%
-13.8%
Q2 2016$7,386,000
+528.6%
162,500
+447.1%
0.09%
+411.8%
Q1 2016$1,175,000
-70.5%
29,700
-57.8%
0.02%
-63.8%
Q4 2015$3,977,000
+19.9%
70,300
-15.7%
0.05%
+2.2%
Q3 2015$3,318,000
+20.0%
83,400
+44.0%
0.05%
+17.9%
Q2 2015$2,765,000
+1.1%
57,900
-16.0%
0.04%
-9.3%
Q1 2015$2,736,000
+24.6%
68,900
-29.9%
0.04%
+30.3%
Q4 2014$2,196,000
+219.2%
98,300
+123.9%
0.03%
+200.0%
Q3 2014$688,000
-43.7%
43,900
-46.7%
0.01%
-42.1%
Q2 2014$1,221,000
+102.8%
82,300
+120.1%
0.02%
+90.0%
Q1 2014$602,000
+82.4%
37,400
+5.9%
0.01%
+100.0%
Q4 2013$330,000
-44.0%
35,300
-32.1%
0.01%
-54.5%
Q3 2013$589,000
-35.9%
52,000
-24.3%
0.01%
-52.2%
Q2 2013$919,00068,7000.02%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 586,700$57,192,0000.02%
GROUP ONE TRADING, L.P. 36,900$3,597,0000.01%
SIMPLEX TRADING, LLC 8,100$789,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders